Matthew Hill

Overview

Matthew Hill is the University of Calgary professor and cannabinoid researcher interviewed in How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill on Huberman Lab. The source presents his work across endocannabinoid signaling, stress, feeding, developmental exposure, cannabis effects, and public-health interpretation.

Current Profile

Hill’s defining role in the wiki is as a scientific corrector who resists both cannabis alarmism and casual safety claims. He distinguishes the precise homeostatic activity of endogenous cannabinoids from broad THC-driven CB1 activation, then repeatedly separates association from causation, commercial labels from chemistry, anecdotes from blinded evidence, and clinical dosing from retail marketing.

His practical frame is conditional rather than binary. Dose, route, potency, tolerance, timing, product composition, psychiatric vulnerability, pregnancy, cardiovascular status, and the treatment indication all change the risk-benefit picture. He treats productive disagreement as part of science: the episode begins with his criticism of Huberman and turns it into explicit revisions around psychosis and indica/sativa claims.

Key Characteristics

• Explains cannabis through endocannabinoid physiology rather than a generic psychoactive-drug label.
• Separates population association, biological plausibility, genetic vulnerability, and causal proof.
• Emphasizes dose, route, potency, tolerance, and user context in harm assessment.
• Challenges commercial strain categories and low-dose CBD claims that outrun blinded or clinical evidence.
• Recognizes selected medical uses while preserving psychiatric, cardiovascular, reproductive, pulmonary, and use-disorder boundaries.
• Models public scientific correction through direct, evidence-focused disagreement.

Evidence

• Mechanistic account: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill explains CB1/CB2 signaling, anandamide, 2-AG, retrograde signaling, and THC’s broad network activation.
• Risk interpretation: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill differentiates acute intoxication, concentrates, edibles, tolerance, use disorder, pregnancy, cardiovascular risk, and psychiatric vulnerability.
• Evidence discipline: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill qualifies schizophrenia causation, strain effects, entourage claims, CBD mechanisms, and medical indications.
• Scientific process: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill begins from Hill’s public criticism and records the resulting corrections rather than hiding the disagreement.

Qualifications

This profile is bounded to one long-form interview and the episode’s supplied summary. It does not independently verify Hill’s full publication record, institutional biography, every cited study, or all cannabis research. Numerical prevalence, dose, timing, pharmacokinetic, and risk claims remain source-scoped public education rather than individualized medical or substance-use advice.

What Changed

• Created the profile from Hill’s account of endocannabinoid biology, cannabis risk, evidence limits, and scientific correction.

Relationships

• Andrew Huberman - host whose earlier cannabis claims Hill challenges and helps revise.
• Huberman Lab - podcast setting for the corrective scientific discussion.
• Endocannabinoid Homeostatic Signaling - core biological system Hill explains.
• Cannabis Dose-Route-Vulnerability Framework - conditional risk framework central to his public-health approach.
• Cannabis-Psychosis Causality Boundary - association-versus-causation distinction he emphasizes.
• Cannabis Strain-Label Evidence Boundary - commercial-label claim he explicitly disputes.
• CBD Evidence-and-Dose Boundary - clinical-versus-retail evidence distinction he develops.